• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

New Podcast Announcement!

Video

Coming soon: the inaugural episode of "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care,” with hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA.

Coming soon: the inaugural episode of "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care,” with hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA.

Related Videos
Danielle Roman, PharmD, BCOP, Allegheny Health Network
UPMC Title Slide Open | Image Credit: © Notebook and Maggie Shaw
UPMC Title Slide Open | Image Credit: © Notebook and Maggie Shaw
UPMC Title Slide Open | Image Credit: © Notebook and Maggie Shaw
Rakendu Rajendran, MBBS, Virtua Health
Dr Brian Mulherin
Dr Brian Mulherin
UPMC Title Slide Open | Image Credit: © Notebook and Maggie Shaw
Related Content
AMGA Logo | Image Credit: AMGA

AMGA Responds to CMS CY 2026 Physician Fee Schedule

November 18th 2025
Article

AMGA advocates for stronger Medicare reimbursement reforms to ensure payment stability and support high-value care amid ongoing challenges for physicians.

Read More

managed care cast logo

Home Health Care Delivery, Outcomes Vary by Payment Model: Rachel A. Prusynski, DPT, PhD

November 18th 2025
Podcast

Rachel A. Prusynski, DPT, PhD, discusses her study on how payment models affect home health care delivery and patient outcomes.

Listen

Cardiologist with older patient | Image credit: Chinnapong – stock.adobe.com

Improving Patient-Centered Cardiovascular Care for Older Adults

November 8th 2025
Article

Experts at AHA 2025 outlined how digital tools, inclusive trials, and safer deprescribing can reshape cardiovascular care for aging adults.

Read More

Inside the Discovery That Changed CML Treatment Forever with Jorge Cortes, MD

Inside the Discovery That Changed CML Treatment Forever with Jorge Cortes, MD

November 11th 2025
Podcast

Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival.

Listen

When remission and low-disease-activity states were combined, 68.8% of pathway patients achieved target disease control by 24 months versus 16.7% in usual care. | Image credit: Murrstock - stock.adobe.com

Integrated RA Pathway Improves Outcomes in Real-World Study

October 28th 2025
Article

A multidisciplinary approach that includes addressing social determinants of health reduces time to remission despite higher initial costs.

Read More

Vivek Subbiah, MD | Image: SCRI

SCRI’s Vivek Subbiah, MD, Highlights Trials on Tumor-Agnostic Cancer Therapies During ESMO

October 28th 2025
Article

Explore the future of cancer treatment with tumor-agnostic therapies, as experts unveil promising trials and innovative drug developments at ESMO.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.